|
⚲
|
| Message |
|---|
| Happy Holidays!! thanks for using AUM13F!! |
| Octagon Capital Advisors LP
✚
|
|
|---|---|
| CRD # | 306424 |
| SEC # | 801-118554 |
| CIK # | 0001839435 |
| AUM | $919.8 M (2025-03-17) |
| Employees | 10 (70% Investors, 0% Brokers) |
| Phone | 212-369-2829 |
| Address | 654 Madison Avenue, 21st Floor New York, NY 10065 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Magenta Therapeutics Inc | 43.6 | ||
| Arrivent Biopharma Inc | 42.4 | ||
| Verona Pharma PLC | 31.9 | ||
| Taysha Gene Therapies Inc | 29.1 | ||
| Silverback Therapeutics Inc | 23.6 | ||
| Gossamer Bio Inc | 22.6 | ||
| Ocular Therapeutix Inc | 22.5 | ||
| Merus NV | 20.5 | ||
| Trevi Therapeutics Inc | 20.1 | ||
| UNUM Therapeutics Inc | 19.8 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold ($M) | AUM ($M) |
|---|---|---|---|---|
| PE | Octagon Private Opportunities Fund II LP | [2025-03-17] | 16.5 | 46.4 |
| PE | Octagon Special Opportunities Fund LP | [2022-03-21] | 66.0 | 26.7 |
| PE | Octagon Private Opportunities Fund LP | [2021-03-18] | 66.0 | 110.8 |
| HF | Octagon Investments Master Fund LP | [2019-11-08] | 701.5 | 735.9 |
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 919.8 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 919.8 |
| By Discretionary | ||
| Discretionary | 8 | 919.8 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 919.8 |
| By Non-United States Persons | ||
| Non-United States Persons | 756.8 | |
| United States Persons | 163.0 | |
| Total | 8 | 919.8 |
| Form D Directors | # Filings | # Firms | 2011 - 2025 |
|---|---|---|---|
| Jennifer Collins | 227 | ||
| Jonathan Morgan | 50 | ||
| Ting Jia | 16 | ||
| Octagon Capital Advisors LP | 11 | ||
| Octagon Investments GP LLC | 10 |
| EDGAR Form | CIK | 2011 - 2025 |
|---|---|---|
| 13F-HR | [0001839435] | |
| SC 13G | [0001839435] |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Sandler Capital Management
✚
|
NY | 0.9 |
|
Taiyo Pacific Partners LP
✚
|
WA | 0.9 |
|
Toscafund Asset Management LLP
✚
|
0.9 | |
|
IBEX Investors LLC
✚
|
CO | 0.9 |
|
First Sentier Investors US LLC
✚
|
NY | 0.9 |
|
Upper90 Capital Management LP
✚
|
RI | 0.9 |
|
FCO Advisors LP
✚
|
NY | 0.9 |
|
HCSF Management LLC
✚
|
CA | 0.9 |
|
Lapis Advisers LP
✚
|
CO | 0.9 |
|
Bay Point Advisors LLC
✚
|
GA | 0.9 |